Irovel H 300 (Irbesartan/HCTZ) in Kenya

Irovel H 300 (Irbesartan/HCTZ) in Kenya

KSh 2,680.00

Irovel H 300 is a fixed-dose combination containing irbesartan 300mg (angiotensin II receptor blocker) and hydrochlorothiazide (HCTZ) 12.5mg (thiazide diuretic). It treats hypertension when monotherapy fails, offering dual action: irbesartan relaxes blood vessels while HCTZ promotes sodium/water excretion. Available as film-coated tablets, it requires prescription and monitoring.

Irovel H 300 (Irbesartan/HCTZ) in Kenya

KSh 2,680.00

Add to cart
Buy Now
Description

Product Description

Overview

Irovel H 300 is a fixed-dose combination containing irbesartan 300mg (angiotensin II receptor blocker) and hydrochlorothiazide (HCTZ) 12.5mg (thiazide diuretic). It treats hypertension when monotherapy fails, offering dual action: irbesartan relaxes blood vessels while HCTZ promotes sodium/water excretion. Available as film-coated tablets, it requires prescription and monitoring.

Composition

Component
Dose per Tablet
Function
Irbesartan 300mg Blocks angiotensin II receptors (vasodilation).
Hydrochlorothiazide 12.5mg Inhibits sodium reabsorption (diuresis).
Inactive Ingredients: Microcrystalline cellulose, lactose, croscarmellose sodium, magnesium stearate.

Side Effects

Common

  • Dizziness/Fatigue: Due to BP reduction.
  • Electrolyte Imbalances: Hypokalemia (low potassium), hyponatremia (low sodium).
  • Muscle Cramps: From HCTZ-induced electrolyte loss.
  • Increased Urination: HCTZ effect (take in morning).

Serious Risks

  • Hypotension: Severe BP drop (risk in volume-depleted patients).
  • Renal Impairment: Worsening kidney function (monitor creatinine).
  • Hyperuricemia: Elevated uric acid (gout risk).
  • Hyperglycemia: HCTZ may raise blood sugar (monitor in diabetics).
  • Angioedema: Facial/throat swelling (rare; discontinue immediately).

How to Use

  • Dosage:
    • Starting: 1 tablet (300mg/12.5mg) once daily.
    • Max Dose: 1 tablet/day (higher HCTZ doses not recommended).
  • Administration:
    • Take in the morning to avoid nocturia.
    • With or without food.
  • Monitoring:
    • Blood Pressure: Check every 2–4 weeks until stable.
    • Electrolytes: Potassium, sodium, creatinine at baseline, then every 3–6 months.
    • Renal Function: eGFR every 6 months.
  • Precautions:
    • Avoid if: Severe renal impairment (eGFR <30 mL/min), pregnancy, sulfa allergy (HCTZ).
    • Drug Interactions:
      • NSAIDs (e.g., ibuprofen): Reduce efficacy and increase renal risk.
      • Potassium Supplements/ACE Inhibitors: Increase hyperkalemia risk.
      • Lithium: Increased lithium toxicity.
      • Digoxin: HCTZ may increase digoxin levels.

Frequently Asked Questions

  1. Is Irovel H 300 available over-the-counter?
    No – prescription-only by physicians.

  2. Does NHIF cover it?
    Partially – covered for hypertension under chronic illness scheme (co-payment required).

  3. Can it be used for heart failure?
    Off-label – sometimes used but not first-line.

  4. What if potassium levels drop?
    Stop immediately and consult a doctor; may need potassium supplements.

  5. Are there cheaper alternatives?
    Yes – generic irbesartan/HCTZ (e.g., Irbes-H) costs KES 1,000–2,000/month. Losartan/HCTZ is cheaper (KES 800–1,500/month).

  6. Is it safe during pregnancy?
    No – discontinues immediately if pregnancy detected (teratogenic).

  7. How long does one pack last?
    30 days (1 tablet/day).

Conclusion

Irovel H 300 offers a convenient, once-daily option for treatment-resistant hypertension in Kenya, combining irbesartan’s vasodilatory benefits with HCTZ’s diuretic effect. While cost-effective (KES 2,500–4,000/month) and partially NHIF-covered, it demands rigorous electrolyte/renal monitoring. Patients with diabetes or gout require extra vigilance due to HCTZ’s metabolic effects. For uncomplicated hypertension, separate components may allow flexible dosing, but Irovel H improves adherence in polypharmacy scenarios. Regular BP and lab checks are essential to prevent hypotension, electrolyte imbalances, or renal decline. Always prioritize lifestyle modifications alongside pharmacotherapy.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Irovel H 300 (Irbesartan/HCTZ) in Kenya”

Your email address will not be published. Required fields are marked *

Top